BURLINGTON, MA (TheStreet) -- Swallowing the tiny live eggs of pig parasites doesn't help treat Crohn's disease. Coronado BioSciences' (CNDO) experimental (and frankly, disgusting) drug CNDO-21 blew up Monday as the company announced failed results from an important phase II study.
Coronado shares fell 69% to $1.80 in early trading. The stock lost almost 14% on Friday, a harbinger of Monday's bad news.
CNDO-021 contains the live eggs of a parasite found in the excrement of pigs. When swallowed, the eggs hatch and grow into tiny whipworms which were supposed to stimulate a persons immune system and fight off inflammatory auto-immune diseases like Crohn's.
Except CNDO-021 doesn't work. Crohn's symptoms of patients treated with CNDO-021 failed to respond any better than patients treated with a placebo, Coronado said.The company blamed the negative study results on a higher-than-expected placebo response, which is typically the lame excuse offered when a drug simply doesn't work. -- Reported by Adam Feuerstein in Boston. Follow Adam Feuerstein on Twitter.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV